Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP), sold 10,000 shares at $33.04 ($332K) on 2026-09-30, disclosed to the SEC on 2026-10-01.
Scheduled sale ($332k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.04 | 7,925 | $262K | 78.9% |
| 2 | $33.76 | 2,075 | $70K | 21.1% |
| Total | $33.19 avg | 10,000 | $332K | 100% |
| Filing → |
| RAPP | SELL | 2026-10-23 | $64K | — | Filing → |
| RAPP | BUY | 2026-10-22 | $100K | — | Filing → |
| RAPP | BUY | 2026-10-22 | $249K | — | Filing → |